FK506 enhanced osteoblastic differentiation in mesenchymal cells

Cell Biology International

Volumn 26, Issue 1, 2002, Pages 75-84

  Tang, Lin ^a   Ebara, Sohei ^a   Kawasaki, Satoshi ^a   Wakabayashi, Shinji ^a   Nikaido, Toshio ^a   Takaoka, Kunio ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alkaline phosphatase; Bone morphogenetic protein; Cell proliferation; Cyclosporin A; FK506; Immunosuppressant; Osteoblastic differentiation; Osteocalcin; Rapamycin; Smad 6

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR; COLLAGEN TYPE 1; COMPLEMENTARY DNA; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; RAPAMYCIN; RNA; SMAD PROTEIN; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; MESENCHYME; MESENCHYME CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0036180694     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1006/cbir.2001.0812     Document Type: Article

References (23)

1. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: A preliminary report
2. The role of testosterone in cyclosporine-induced osteopenia
3. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo
4. The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model
5. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation
6. The mechanisms of action of cyclosporine and FK506
7. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblastic cells in vitro
8. Smad6 inhibits signalling by the TGF-beta superfamily
9. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2
10. Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation
11. Mechanisms of action of cyclosporine
12. Signal transduction by bone morphogenetic protein receptors: Fuctional roles of Smad proteins
13. Rosveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells
14. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization
15. Osteoblastic differentiation is enhanced by rapamycin in rat osteoblatic-like osteosarcoma (ROS 17/2.8) cells
16. Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid
17. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix
18. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor
19. Rapamycin: A bone sparing immunosuppressant?
20. Gene cloning and expression of a bone morphogenetic protein derived from a murine osteosacoma
21. Novel regulators of bone formation: Molecular and activities
22. Effects of BMP-2, BMP-4 and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6
23. In vivo osteogenic capability of cultured allogenic bone in porous hydroxyapatite immunosuppressive and osteogenic potential of FK506 in vivo